Treating
Cancers
In Companion
Animals
We develop novel, off-the shelf, as well as patient tailored immunotherapies for solid cancers.
Our belief is that the study and treatment of naturally developing cancer in man’s best friend can yield effective therapeutic solutions for humans as well.
Cancer is the #1 cause of death in dogs & cats, but still veterinary medicine is decades behind human medicine. Pet owners want better therapies for their four-legged family member.
Immuvera Therapeutics is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.
Four Decades
Of Veterinary Oncology experience
Four Patent Families
First granted
First Therapy
Already being tested in dogs
"Seeing how our innovative immunotherapy protocols are giving hope to pet owners facing cancer diagnoses is what drives our work. We're bridging the gap between human and veterinary oncology for better outcomes."
Dr. Lars Moe
Chief Medical Officer
